The research has been snapped up by pharmaceutical giant Teva, and according to the lead author could mean an ‘arsenal of new drugs’

White blood cells initially combat brain cancer — but then ‘guard’ the tumor and help it grow. Tel Aviv scientists behind finding believe discovery will lead to better treatments

Tumors in mice lost half their size when injected with eosinophils, best known for inducing allergies; promising results also seen in human tumor cells in vitro

Startup's blood test aims to predict which cancer patients will react better to treatment; 8 clinical trials will be set up in the UK

Funding will help advance the clinical development of firm's flagship drug for the treatment of solid and blood cancers via multiple clinical trials

Tiny silicone chip sits in a petri dish simulating diseased cells, allowing scientists to check how well immunotherapies fare against illness

Texas's Cancer Focus Fund will support a Phase 1/2 clinical study assessing Israeli company's flagship drug, which uses 2 proteins - 1 to mark cancer cells and 1 to weaken them

Joint research aims to find microbiome-based drugs that will enhance patient response and reduce adverse effects of immunotherapies in melanoma patients

KAHR's leading drug candidate, now in clinical trials, is based on a compound that targets cancer cells, weakens their defenses and activates a local immune response

Immunotherapy needs peptides to work, but if a patient has too few, anti-cancer drugs will fall short; discovery of new type by Weizmann Institute-led team could solve problem